Marble Harbor Investment Counsel’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,690
Closed -$202K 199
2023
Q3
$202K Hold
2,690
0.03% 183
2023
Q2
$207K Hold
2,690
0.03% 180
2023
Q1
$223K Hold
2,690
0.03% 179
2022
Q4
$231K Buy
+2,690
New +$213K 0.03% 170
2017
Q1
Sell
-3,455
Closed -$247K 152
2016
Q4
$247K Sell
3,455
-375
-10% -$27.9K 0.06% 136
2016
Q3
$303K Buy
3,830
+500
+15% +$40.6K 0.07% 123
2016
Q2
$278K Buy
3,330
+30
+0.9% +$2.66K 0.07% 123
2016
Q1
$303K Buy
3,300
+625
+23% +$56.4K 0.07% 114
2015
Q4
$271K Buy
+2,675
New +$278K 0.07% 114
2015
Q3
Sell
-1,925
Closed -$225K 131
2015
Q2
$225K Buy
+1,925
New +$210K 0.06% 122

Other funds holding GILD

Marble Harbor Investment Counsel's GILD Position: Q4 2023 in Review

Marble Harbor Investment Counsel sold out of Gilead Sciences (GILD) in Q4 2023, closing a stake of 2,690 shares — an estimated $202K sold.

Marble Harbor Investment Counsel first reported a position in GILD in Q2 2015 and held it in 10 quarters. The position peaked at $303K in Q3 2016. 1,776 funds tracked by Wall St. Rank hold GILD as of Q4 2023.

  • Marble Harbor Investment Counsel reported no remaining Gilead Sciences position as of Q4 2023 after selling out during the quarter.
  • Marble Harbor Investment Counsel sold 2,690 Gilead Sciences shares in Q4 2023, an estimated $202K.
  • Marble Harbor Investment Counsel first reported a position in Gilead Sciences in Q2 2015 and held it in 10 quarters.
  • Marble Harbor Investment Counsel's Gilead Sciences position peaked at $303K in Q3 2016.
  • 1,776 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2023.

Based on Marble Harbor Investment Counsel's 13F filing for Q4 2023, filed 9 Feb 2024.